Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03867409 · ClinicalTrials.gov registry record · NA
The United States Healthy Living Study
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 2,105
- Enrollment target
NCT03867409: Completed NA study, sponsored by University of Florida.
NCT03867409 is a NA study that has completed, run by University of Florida. The registered enrollment target is 2,105 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (50% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03867409, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,105 participants
- Enrollment target
Study Summary
The purpose of this study is to pilot test the efficacy of a patient-centered, tailored message intervention delivered via virtual human technology for increasing colorectal cancer (CRC) screening within guidelines. Although participation is not limited to these groups, the study team is particularly interested in the feasibility of the intervention for reaching racial/ethnic minority and rural patients.
Primary Outcome
Measure: Intention to talk to doctor about colorectal cancer screening. Construct: Behavioral intention to communicate Item: The virtual appointment made me want to discuss colon cancer screening options with my doctor. Scale: 5-point Likert scale (1 = strongly disagree to 5 = strongly agree). Mean scores near 1 indicate a lower intention to talk to a healthcare professional about colorectal cancer screening. Mean scores near 5 indicate a high intention to talk to a healthcare professional abou
Interventions
- BEHAVIORAL message delivered via virtual technology
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,105 participants |
| Start Date | 2018-11-05 |
| Est. Completion | 2019-03-14 |
| Phase | NA |
What the finished NCT03867409 record still lists
NCT03867409 is an interventional study that assigns participants to a tested intervention. Its 2,105 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (50% higher).
The record links to 0 conditions, and to 1 intervention - of which message delivered via virtual technology is the first listed.
NCT03867409 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03867409 about?
NCT03867409 is a clinical study titled "The United States Healthy Living Study". The purpose of this study is to pilot test the efficacy of a patient-centered, tailored message intervention delivered via virtual human technology for increasing colorectal cancer (CRC) screening within guidelines. Although participation is not limited to these groups, the study team is particularl...
What is the current status of trial NCT03867409?
This trial is currently completed. It is a NA study. The enrollment target is 2,105 participants. The study started on 2018-11-05. Estimated completion is 2019-03-14.
What interventions are being tested in trial NCT03867409?
The interventions under investigation include: message delivered via virtual technology (BEHAVIORAL).
Who is sponsoring clinical trial NCT03867409?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03867409's enrollment target sits among peer trials
2,105 49th of 2000 higher than 1,952 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05967273 · 2,106 participants · NA
CirrhosisRx CDS System
- NCT04649242 · 2,100 participants · Phase 3
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- NCT05206331 · 2,100 participants · Phase 4
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study
- NCT05270499 · 2,100 participants
Aveir VR Real-World Evidence Post-Approval Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI